![](https://www.uclawsf.edu/wp-content/uploads/2020/09/blue-update-logo-01.png)
Patent Database Exposes Pharma’s Pricey “Evergreen” Strategy
September 24, 2020
AstraZeneca, Johnson & Johnson and Gilead lead a crowded field of drug makers who excessively extend patent protections to limit the market entry of competing products in an anti-competitive practice called “evergreening,” a primary driver of high drug prices. This is one finding of many according to a public…